Health Affairs Publishing’s Jeff Byers welcomes Georgetown University’s Katie Keith and Deputy Editor Chris Fleming back to the podcast to unpack a new court case over mifepristone that could alter telehealth access to medication abortion and test the boundaries of FDA authority.

Join us on June 23 for an exclusive Insider virtual event examining how antitrust policy in health care is evolving at both the federal and state levels, featuring insights from Katherine Gudiksen, Leemore Dafny, and Nathan Hostert.

Related Links:

• Supreme Court Temporarily Blocks Ruling Barring Telehealth And Pharmacy Access To Mifepristone (Health Affairs Forefront)
• The US Food and Drug Administration’s Regulation of Mifepristone (JAMA)

Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.

Welcome to the first episode in a new, limited podcast series exploring major policy changes affecting older adults. The episode is part of our Age-Friendly Health series, which explores topics at the intersection of aging, health, health care, and health policy.

In our first episode, host Katherine Ornstein welcomes Hemi Tewarson of the National Academy for State Health Policy how the The Big Beautiful Bill will impact Medicaid and state health policies affecting older adults. Their conversation explores work requirements, Medicaid financing changes, rural health investments, the sustainability of age‑friendly services, and more.

Support for the Age-Friendly Health series is provided by The John A. Hartford Foundation.

Health Affairs Publishing's Jeff Byers welcomes Duke University School of Medicine's Mike Pignone to the pod to explore the new cholesterol screening guidelines, how evolving screening and treatment guidelines (including colon cancer and breast cancer screening guidelines) influence care, and the broader cost implications for the health system.

Join Health Affairs Publishing on May 13 for an exclusive Insider virtual event exploring individual coverage health reimbursement arrangements (ICHRAs) with Urban Institute’s Jason Levitis.

Related Articles:

• Generic cholesterol drugs save Medicare billions of dollars, study finds (UT Southwestern Medical Center)
• Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol–Lowering Therapies Among Medicare Beneficiaries (JAMA)
• A cholesterol test you've never heard of is now recommended to prevent heart disease (NPR)
• ACC/American Heart Association Issue Updated Guideline for Managing Lipids, Cholesterol (American Heart Association)

Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.